A systematic review of disease related stigmatization in patients living with prostate cancer.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
08
2021
accepted:
05
12
2021
entrez:
11
2
2022
pubmed:
12
2
2022
medline:
3
3
2022
Statut:
epublish
Résumé
Prostate cancer has been shown to be susceptible to significant stigmatisation, because to a large extent it is concealable, it has potentially embarrassing sexual symptoms and has significant impact on the psychosocial functioning. This review included studies that focused on qualitative and/or quantitative data, where the study outcome was prostate cancer and included a measure of stigmatization. Electronic databases (CINAHL, Medline, PubMed, PsycInfo, Cochrane Library, PROSPERO, and the Joanna Briggs Institute) and one database for grey literature Opengrey.eu, were screened. We used thematic analysis, with narrative synthesis to analyse these data. We assessed risk of bias in the included studies using the RoBANS. In total, 18 studies met review inclusion criteria, incorporating a total of 2295 participants. All studies recruited participants with prostate cancer, however four studies recruited participants with other cancers such as breast cancer and lung cancer. Of the 18 studies, 11 studies evaluated perceived or felt stigma; four studies evaluated internalised or self-stigma; three studies evaluated more than one stigma domain. We found that patients living with prostate cancer encounter stigmatisation that relate to perception, internalisation, and discrimination experiences. We also identified several significant gaps related to the understanding of prostate cancer stigmatization, which provides an opportunity for future research to address these important public health issues. This systematic review protocol is registered with PROSPERO, the international prospective register of systematic reviews in health and social care. Registration number: CRD42020177312.
Sections du résumé
BACKGROUND
Prostate cancer has been shown to be susceptible to significant stigmatisation, because to a large extent it is concealable, it has potentially embarrassing sexual symptoms and has significant impact on the psychosocial functioning.
METHODS
This review included studies that focused on qualitative and/or quantitative data, where the study outcome was prostate cancer and included a measure of stigmatization. Electronic databases (CINAHL, Medline, PubMed, PsycInfo, Cochrane Library, PROSPERO, and the Joanna Briggs Institute) and one database for grey literature Opengrey.eu, were screened. We used thematic analysis, with narrative synthesis to analyse these data. We assessed risk of bias in the included studies using the RoBANS.
RESULTS
In total, 18 studies met review inclusion criteria, incorporating a total of 2295 participants. All studies recruited participants with prostate cancer, however four studies recruited participants with other cancers such as breast cancer and lung cancer. Of the 18 studies, 11 studies evaluated perceived or felt stigma; four studies evaluated internalised or self-stigma; three studies evaluated more than one stigma domain.
DISCUSSION
We found that patients living with prostate cancer encounter stigmatisation that relate to perception, internalisation, and discrimination experiences. We also identified several significant gaps related to the understanding of prostate cancer stigmatization, which provides an opportunity for future research to address these important public health issues.
REGISTRATION
This systematic review protocol is registered with PROSPERO, the international prospective register of systematic reviews in health and social care. Registration number: CRD42020177312.
Identifiants
pubmed: 35148315
doi: 10.1371/journal.pone.0261557
pii: PONE-D-21-26750
pmc: PMC8836305
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0261557Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Epidemiol Community Health. 1984 Dec;38(4):284-90
pubmed: 6512480
Patient Prefer Adherence. 2018 Jul 24;12:1305-1314
pubmed: 30087556
Cancer Nurs. 2005 Nov-Dec;28(6):415-24
pubmed: 16330962
Rev Urol. 2004 Spring;6(2):73-81
pubmed: 16985580
Am J Mens Health. 2018 Nov;12(6):1807-1823
pubmed: 30203706
J Health Soc Behav. 1994 Jun;35(2):118-33
pubmed: 8064120
LGBT Health. 2015 Dec 24;3(1):49-56
pubmed: 26698658
Eur J Cancer Care (Engl). 2020 Jan;29(1):e13183
pubmed: 31642565
J Fam Psychol. 2007 Dec;21(4):572-83
pubmed: 18179329
Can J Psychiatry. 2012 Aug;57(8):464-9
pubmed: 22854028
BMC Health Serv Res. 2010 Mar 25;10:80
pubmed: 20338040
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Psychol Health Med. 2006 Aug;11(3):307-34
pubmed: 17130068
J Health Commun. 2017 Jun;22(6):469-476
pubmed: 28414570
Int J Rehabil Res. 2007 Sep;30(3):235-8
pubmed: 17762770
J Psychosoc Oncol. 2019 May-Jun;37(3):350-366
pubmed: 30580663
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12790
pubmed: 29112317
Support Care Cancer. 2019 Sep;27(9):3337-3345
pubmed: 30617433
J Natl Cancer Inst. 2004 Dec 15;96(24):1813-22
pubmed: 15601637
Ann Intern Med. 1993 May 15;118(10):793-803
pubmed: 8470854
Psychooncology. 2018 Jan;27(1):193-198
pubmed: 28685499
Eur J Cancer Care (Engl). 2019 Mar;28(2):e12977
pubmed: 30548713
J Health Soc Behav. 2000 Mar;41(1):50-67
pubmed: 10750322
Urology. 1997 Dec;50(6):920-8
pubmed: 9426724
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Cancer Surv. 1995;23:63-77
pubmed: 7621474
Acta Oncol. 2014 Jul;53(7):958-65
pubmed: 24456505
Psychol Health. 2009 Oct;24(8):949-64
pubmed: 20205038
Recent Results Cancer Res. 2016;208:137-153
pubmed: 27909906
BMC Public Health. 2021 Apr 23;21(1):779
pubmed: 33892683
Milbank Mem Fund Q Health Soc. 1976 Fall;54(4):439-67
pubmed: 137366
Int J Ment Health Syst. 2020 Mar 13;14:19
pubmed: 32190107
BMC Cancer. 2019 Jun 11;19(1):566
pubmed: 31185949
J Psychosoc Oncol. 2017 Jul-Aug;35(4):451-467
pubmed: 28318410
Psychooncology. 2011 Mar;20(3):302-12
pubmed: 20878830
BMC Cancer. 2017 Nov 09;17(1):741
pubmed: 29121876
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Urology. 2000 Dec 20;56(6):899-905
pubmed: 11113727
Psychooncology. 2001 May-Jun;10(3):206-17
pubmed: 11351373
Med Care. 2003 Aug;41(8):923-36
pubmed: 12886172
Int J Mol Sci. 2020 Feb 20;21(4):
pubmed: 32093338
Ecancermedicalscience. 2021 Oct 25;15:1308
pubmed: 34824631
BMJ. 2004 Jun 19;328(7454):1470
pubmed: 15194599
J Cult Divers. 2003 Summer;10(2):56-61
pubmed: 14508926
Am Psychol. 2020 Feb-Mar;75(2):274-289
pubmed: 32053000
Psychother Psychosom Med Psychol. 2015 May;65(5):183-90
pubmed: 25794353
BMC Womens Health. 2017 Aug 2;17(1):58
pubmed: 28768506
BJU Int. 2021 Dec;128 Suppl 3:18-29
pubmed: 32627306
Future Oncol. 2008 Aug;4(4):561-8
pubmed: 18684066
Psychooncology. 2000 Jul-Aug;9(4):273-82
pubmed: 10960925
Res Nurs Health. 2001 Dec;24(6):518-29
pubmed: 11746080
Eur Urol. 2013 May;63(5):800-9
pubmed: 23219374
Ecancermedicalscience. 2019 Dec 12;13:989
pubmed: 32010213
Clin Exp Gastroenterol. 2016 Mar 07;9:49-58
pubmed: 27022294
Nurs Res. 2003 Nov-Dec;52(6):370-9
pubmed: 14639083
Adm Policy Ment Health. 2013 Sep;40(5):384-99
pubmed: 22833051
Clin Lung Cancer. 2008 May;9(3):171-8
pubmed: 18621628
Nutrients. 2016 Jul 09;8(7):
pubmed: 27409631
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
Br J Health Psychol. 2020 Sep;25(3):615-638
pubmed: 32678937
Int J Cancer. 2000 Jan 1;85(1):60-7
pubmed: 10585584
Eur J Oncol Nurs. 2018 Apr;33:62-69
pubmed: 29551179
J Clin Oncol. 2003 Oct 15;21(20):3777-84
pubmed: 14551296
BMC Womens Health. 2020 Jun 3;20(1):116
pubmed: 32493375
Future Oncol. 2008 Oct;4(5):717-33
pubmed: 18922128
Sociol Health Illn. 2009 Apr;31(3):441-55
pubmed: 19366430